The surgical robotics maker posts better-than-expected quarterly earnings as it begins rollout of cardiac procedures.

We came across a bullish thesis on Intuitive Machines, Inc. on The Analyst’s Journal’s Substack by A_Capital. In this article ...

Intuitive Machines stock is still a "Buy" amid a 72% gain and reaching out price target. Here's what investors need to know.

With nine new procedures cleared for the da Vinci 5 robot, Intuitive’s strategy includes working with a limited number of U.S ...

The FDA 510(k) clearances for cardiac procedures cover Intuitive's latest-generation da Vinci 5 (DV5) using non-Force ...

This robotic surgical systems pioneer is dealing with a few issues, but its opportunities remain promising.

Intuitive Surgical receives FDA clearance for the da Vinci 5 robot to be used in cardiac procedures, reports 18% procedure ...

Houston’s lunar technology specialist reported a recent insider sale amid ongoing efforts to expand its footprint in space exploration.

This robotics company just put up another quarter of amazing growth, and the reasons to love the stock keep adding up.

Intuitive Surgical, Inc. stock: da Vinci robotics leader with 80% share, recurring revenue, fast procedure growth and solid moat. Click for why I'm bullish on ISRG.

Fourth quarter 2025 GAAP net income attributable to Intuitive was $795 million, or $2.21 per diluted share, compared with $686 million, or $1.88 per diluted share, in the fourth quarter of 2024.